Publication

Article

BioPharm International

BioPharm International-11-01-2012
Volume25
Issue 11

BioPharm International, November 2012 Issue (PDF)

Biosimilars : New Guidelines Set for Monoclonal Antibodies

To view a PDF of this article from the BioPharm International archives, click this link

Articles in this issue
BioPharm International, November 2012 Issue (PDF)
Simon-Chalk-796150-1416911935154.jpg
The Transformation to Process-Centered Organization
ThinkStock_106522811-796156-1408596717283.jpg
Considerations for Scale-Up of Stem-Cell Cultures
Brandyberry-Headshot-796146-1408596742879.jpg
Creating a Holistic Procurement System
Product Characterization: A Primer
Retrospective_Protein-Recov-796157-1408596713154.gif
A 25-Year Retrospective on Protein Recovery through Membrane Filters

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!
Related Videos
How the 15% US-EU Tariff Cap Affects Bio/pharma
Dave Miller, PhD, Chief Scientific Officer, AustinPx
Dave Miller, PhD, Chief Scientific Officer, AustinPx
Related Content
PRAGUE, CZECHIA - NOVEMBER 1, 2019: Astellas logo in front of their main office for Prague. Astellas Pharma is a Japanese Pharmaceutical company spread worldwide | Image Credit: © Jerome - stock.adobe.com
August 23rd 2025

Astellas and Pfizer Bladder Cancer Therapy Recommended by UK’s NICE

Patrick Lavery
The Future of Cleanroom Construction: How Hybrid Solutions are Changing the Game
August 23rd 2025

The Future of Cleanroom Construction: How Hybrid Solutions are Changing the Game

G-CON
Bio/Pharma's Response to Tariff and Trade Policy
August 23rd 2025

Bio/Pharma's Response to Tariff and Trade Policy: Survey Results

Christopher Cole
Mastering Antibody-Drug Conjugates
August 23rd 2025

Mastering Antibody-Drug Conjugates

BIOVECTRA
The front of the REGENXBIO facility in Rockville, Montgomery County, Maryland. REGENXBIO is a biotechnology company researching Adeno-Associate Virus (AAV) gene therapy | Image Credit: © MJ Kerr - stock.adobe.com
August 23rd 2025

FDA Extends Review Period for REGENXBIO Hunter Syndrome Treatment

Patrick Lavery
Lung cancer, 3D illustration and photo under microscope. Histopathology light micrograph of small cell lung cancer | Image Credit: © Dr_Microbe - © Dr_Microbe - stock.adobe.com
August 23rd 2025

Merck and Daiichi Sankyo’s I-DXd Earns FDA Breakthrough Therapy Status in Small Cell Lung Cancer

Feliza Mirasol
© 2025 MJH Life Sciences

All rights reserved.